Want to see JP:4694 full AI Analyst Report?
BML (4694) Stock Price & Analysis
4694 Stock Chart & Stats
- Day’s Range
- JPY 3,775.00 - JPY 3,850.00
- 52-Week Range
- JPY 3,370.00 - JPY 4,385.00
- Previous Close
- JPY 3,835.00
- Volume
- N/A
- Average Volume (3M)
- 71.10K
- Market Cap
- JPY 143.41B
- Enterprise Value
- JPY 90.66B
- Total Cash (Recent Filing)
- JPY 53.36B
- Total Debt (Recent Filing)
- JPY 4.68B
- Price to Earnings (P/E)
- 18.1
- Beta
- 0.35
- Next Earnings
- Nov 11, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 3.37%
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Very low leverage and substantial equity support solvency, reduce financial risk, and preserve flexibility to fund operations or investments through changing conditions.
Return To Revenue Growth
The return to revenue growth and improved net income indicate that the business is stabilizing after earlier declines, supporting a more durable earnings base if operating performance remains consistent.
Ongoing Profitability
Positive margins demonstrate that the company continues to generate earnings from its operations, providing internal funding capacity and resilience despite weaker profitability than in prior peak periods.
Bears Say
Revenue And Margin Volatility
The post-peak revenue declines and sustained margin compression suggest lower earnings power and make medium-term growth and profitability less predictable than during the company’s stronger prior periods.
Uneven Free Cash Flow
Variable cash conversion may reflect working-capital swings or investment needs, limiting the reliability of internally generated funds and making dividends, reinvestment, and balance-sheet planning less predictable.
Lower Capital Efficiency
Although solvency is strong, the decline in return on equity indicates that the enlarged capital base is producing less profit than before, which can constrain long-term earnings growth and shareholder returns.
4694 FAQ
What was BML’s price range in the past 12 months?
What is BML’s market cap?
When is BML’s upcoming earnings report date?
How were BML’s earnings last quarter?
Is BML overvalued?
Does BML pay dividends?
What is BML’s EPS estimate?
How many shares outstanding does BML have?
What happened to BML’s price movement after its last earnings report?
Which hedge fund is a major shareholder of BML?
What is the TipRanks Smart Score and how is it calculated?
Company Description
BML
BML, Inc. is a Japanese corporation specializing in a comprehensive range of laboratory diagnostics and related services. The company conducts standard analyses such as biochemical and hematological screenings, in addition to advanced specialized tests including radioimmunoassay (RIA), cellular diagnostics, immunology, and DNA analysis. It also provides microbiological assessments for medical and pharmaceutical organizations, along with diagnostic services covering critical areas like oncology, infectious diseases, metabolic disorders (diabetes, hypertension), allergies, and genetic studies. To optimize laboratory operations, BML develops proprietary automation systems, Frontier and Symphony, designed to streamline processes from initial sample sorting and dispensing through to subsequent testing. The firm also supports medical information networking via electronic health records and offers preventative healthcare solutions. BML's extensive service portfolio includes food safety and environmental health. Its food division provides comprehensive hygiene control and processing support, encompassing contractual microbiological testing for raw ingredients, prepared, and processed foods. This extends to environmental hygiene assessments for food facilities and kitchens, general microorganism testing, and the evaluation of genetically modified organisms. Environmental services comprise drinking water and wastewater analysis, occupational health management (measuring airborne substances like ethylene oxide, formaldehyde, organic solvents, and dust), comprehensive indoor environmental monitoring (identifying contaminants and other variables), and biological dioxin surveillance. Moreover, BML performs analyses for residual agricultural chemicals, offers dental diagnostics for caries and periodontal diseases, provides consulting for pharmaceutical product approvals, conducts investigative analyses for drug manufacturers, and performs gene expression analysis, specifically identifying genes linked to infectious disease susceptibility. Founded in 1955, BML, Inc. is headquartered in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Kensuke Kondo
- Employees
- 4,612
- Website
- www.bml.co.jp
- Address
- 5-21-3 Sendagaya, Tokyo, TY, 151-0051, JP
BML (4694) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 6 | 4 |
| Technical Analysis | 4 | 6 | 0 |
| Moving Averages | 8 | 0 | 4 |







